Eli Lilly CFO on Q2 earnings and coronavirus treatment

Eli Lilly reports results from Covid-19 phase 2 antibody drug trialПодробнее

Eli Lilly starts first study of potential COVID-19 antibody treatmentПодробнее

Lilly Aims to Produce 100K Covid-19 Antibody Doses by Year End: CFOПодробнее

Citing Safety Reasons, Eli Lilly Halts COVID Treatment TrialПодробнее

Coronavirus: Eli Lilly coronavirus treatment authorized by FDA for emergency useПодробнее

Eli Lilly CEO on Q2 earnings and core business performanceПодробнее

Eli Lilly CEO on how Covid-19 antibody drug helped drive Q4 earningsПодробнее

Eli Lilly CEO discusses its coronavirus antibody drug and the latest on its breast cancer treatmentПодробнее

Eli Lilly CEO on raising $1B for antibiotic research: Goal is to have two to four new antibioticsПодробнее

Covid-19 Vaccine Update | India Gives Emergency Use Approval To Eli Lilly's Covid Antibody DrugПодробнее

Eli Lilly’s chief scientific officer on Covid antibody drug resultsПодробнее

Eli Lilly to supply federal government with 388K doses of COVID treatment drugПодробнее

Eli Lilly beats on Q2 revenue and profit driven by 'a collection' of name brand drug sales: AnalystПодробнее

Eli Lilly’s Coronavirus Antibody Treatment Trial Halted | NBC Nightly NewsПодробнее

Eli Lilly’s Covid-19 Antibody Treatment Faces Distribution Challenges | NBC Nightly NewsПодробнее

Eli Lilly CFO resigns over 'inappropriate' communicationПодробнее

Eli Lilly hopes to start testing coronavirus cure 'this summer': CEOПодробнее

Eli Lilly pausing Covid-19 trials is not a big deal: Jefferies managing directorПодробнее

Eli Lilly confirms it has paused one of its Covid-19 antibody testsПодробнее